Clinical Trial Detail

NCT ID NCT04434560
Title Neoadjuvant Immunotherapy in Brain Metastases
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Sarah Sammons, MD
Indications

transitional cell carcinoma

triple-receptor negative breast cancer

ovarian carcinoma

lung squamous cell carcinoma

renal cell carcinoma

melanoma

lung non-squamous non-small cell carcinoma

Advanced Solid Tumor

Therapies

Ipilimumab + Nivolumab

Age Groups: senior adult

Additional content available in CKB BOOST